JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Trevena (TRVN) Prices $50M Public Offering of Common Stock at $2.30/sh
-
Trevena Announces Pricing of $50 Million Public Offering of Common Stock
-
ACADIA Pharmaceuticals to Present at The JMP Securities CNS Forum on August 19, 2020
-
Shutterstock (SSTK) Prices 2.58M Common Stock Offering at $48.50/sh
-
Shutterstock Announces Pricing of Public Offering of Common Stock
-
JMP Group Announces Changes in Sales and Trading Leadership
-
MVC Capital, Inc. To Merge With Barings BDC, Inc.
-
Shutterstock (SSTK) Announces $250M Proposed Public Offering of Common Stock
-
Shutterstock Announces Proposed Public Offering of Common Stock
-
Trevena (TRVN) PT Raised to $6 at JMP Securities, After FDA Approval Received
-
Baudax Bio Reports Second Quarter 2020 Financial Results
-
Baudax Bio Reports Second Quarter 2020 Financial Results
-
Companies with NDRs 08/10
-
StoneCastle Financial (BANX) PT Lowered to $22 at JMP Securities, Following Earnings
-
Ready Capital Corp. (RC) PT Raised to $12 at JMP Securities, Following Earnings
-
Duck Creek Technologies Launches Initial Public Offering
-
Duck Creek Technologies Launches Initial Public Offering
-
Cortexyme Announces Webcasts of Investor Conference Presentations in August 2020
-
Syros Pharmaceuticals (SYRS) PT Raised to $20 at JMP Securities, Following Earnings
-
Driven Deliveries Announces Participation in JMP Securities' Cannabis Technology Virtual Forum on August 18, 2020
-
Companies with NDRs 08/06
-
Spectrum Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Hot Penny Stocks To Buy Right Now According To Analysts
-
Kinsale Capital Group (KNSL) Prices 270K Share Common Offering at $190/Sh
-
Kinsale Capital Group Announces Pricing of Public Offering of Common Stock
-
Kinsale Capital Group Announces Pricing of Public Offering of Common Stock
-
Kinsale Capital Group (KNSL) Announces Proposed Public Offering of Common Stock
-
Kinsale Capital Group Announces Proposed Public Offering of Common Stock
-
Kinsale Capital Group Announces Proposed Public Offering of Common Stock
-
Exantas Capital Corp. (XAN) Announces Acquisition of Management Contract from C-III Capital Partners by ACRES Capital Corp. and $375 Million Financing from MassMutual and Oaktree Capital Management
-
Exantas Capital Corp. Announces Acquisition of Management Contract from C-III Capital Partners by ACRES Capital Corp. and $375 Million Financing from MassMutual and Oaktree Capital Management
-
Piper Sandler (PIPR) PT Raised to $71 at JMP Securities, Following Earnings
-
GrubHub Inc. (GRUB) Growth Metrics Continue to Accelerate - JMP Securities
-
JMP Group Announces Management Changes
-
Capstead Mortgage (CMO) PT Raised to $6.50 at JMP Securities, Following Earnings
-
Spectrum Pharma (SPPI) Prices 21.67M Share Common Offering at $3/Sh
-
Spectrum Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Karuna Therapeutics to Present at Upcoming Investor Conferences
-
Spectrum Pharma (SPPI) Announces Proposed Public Offering of Common Stock
-
Spectrum Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
JMP Group Reports Second Quarter 2020 Financial Results
-
Vertex (VERX) IPO Opens 35% Higher
-
Vertex Announces Pricing of Initial Public Offering
-
Advisor Group Welcomes Richard Page To Ladenburg Thalmann & Co. Inc. As Managing Director In Healthcare Investment Banking Group
-
Pre-Open Stock Movers 07/28: (KODK) (LUMO) (CVLT) Higher; (ALNA) (EDU) (TSLA) Lower (more...)
-
CorMedix (CRMD) Announces Pricing of $20M Public Offering of Common Stock at $4.50/sh
-
CorMedix Announces Pricing of $20M Public Offering of Common Stock
-
UPDATE: JMP Securities Starts Altimmune (ALT) at Market Outperform
-
CorMedix Announces Proposed Public Offering of Common Stock
-
Jamf Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

